What medication has Zydus Lifesciences received approval to sell in China?

Zydus Lifesciences has received approval from the Chinese regulator to sell Venlafaxine extended-release (ER) capsules in the country.

Home / Health / Zydus Lifesciences Approved to Sell Antidepressant in China

Zydus Lifesciences Approved to Sell Antidepressant in China

Q: What conditions can Venlafaxine ER capsules treat?

Venlafaxine ER capsules are indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder.

11 Nov, 2025

•

Summary

Zydus Lifesciences receives approval from Chinese regulator for Venlafaxine ER capsules
Medication treats major depressive disorder, anxiety, and panic disorders
First approval for Zydus in China

Zydus Lifesciences Approved to Sell Antidepressant in China

In a significant development, Zydus Lifesciences, the Gujarat-based pharmaceutical firm, has received approval from China's National Medical Products Administration (NMPA) to market its Venlafaxine extended-release (ER) capsules in the country.

The approved strengths of the medication are 75 mg and 150 mg, and it is indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. Venlafaxine ER helps restore the balance of serotonin and norepinephrine in the brain, thereby improving mood and reducing anxiety.

This approval marks the first time Zydus Lifesciences has received the green light from the Chinese regulator to sell its products in the world's second-largest pharmaceutical market. The company's shares were trading 0.84% lower at Rs 939.05 on the Bombay Stock Exchange as of November 11, 2025.